Holen Sie sich die Stockscreener-App
23.40
7.59%
1.65
Finanzdaten der Vtv Therapeutics Inc-Aktie (VTVT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 0.017 | - | - |
Operating Expenses
|
18.73%
7.721
|
6.503 | 4.909 | 6.506 | 7.155 |
| Operating Income/Loss |
18.73%
-7.721
|
-6.503 | -4.892 | -6.506 | -7.155 |
| Income/Loss From Continuing Operations Before Tax |
18.71%
-7.38
|
-6.217 | -4.437 | -5.84 | -6.409 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
18.71%
-7.38
|
-6.217 | -4.437 | -5.84 | -6.409 |
|
Net Income/Loss
|
18.71%
-7.38
|
-6.217 | -4.437 | -5.84 | -6.409 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
18.58%
-1.334
|
-1.125 | -0.803 | -1.057 | -1.229 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):